Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation

November 28, 2018 by admin 2018 Press Releases 0 comments

Washington, DC (November 28, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement in conjunction with “Reducing Health Care Costs: Improving Affordability Through Innovation,” a hearing before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP):

“The Healthcare Supply Chain Association applauds Senate HELP Committee Chair Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) for their leadership and emphasis on reducing healthcare costs through innovation. As the sourcing and purchasing partners to American hospitals, long-term care facilities, surgery centers, clinics, and other healthcare providers, healthcare group purchasing organizations (GPOs) are committed to lowering healthcare costs by increasing competition and innovation in the healthcare marketplace.

Read the full statement…

 

Prev
Next

Related Posts

HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
March 9, 2018

Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph.,...

Learn more
HSCA Announces Healthcare Cybersecurity Key Considerations
April 17, 2018

The Healthcare Supply Chain Association (HSCA) today announced the release of key...

Learn more
HSCA Comments on DEA Proposed Rule on Opioid Production Limits
May 4, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Comments on FDA Bulk Substance Guidance
May 25, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
    May 8, 2025
  • HSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
    March 12, 2025